Nobuyoshi Maeji - Anteo Diagnostics Insider

Anteo Diagnostics Limited -- Australia Stock  

AUD 0.01  0.01  50%

Chief Scientific Officer

Dr. Nobuyoshi Joe Maeji, Ph.D., is Founder, Chief Scientific Officer of Anteo Diagnostics Limited. Dr. Joe Maeji is the founder of BioLayer. Prior to forming Bio Layer, Dr. Maeji held the position of Head of Research for Mimotopes Pty Ltd and Sr. Director for Small Molecule Drug Discovery for Chiron. At Mimotopes Pty Ltd., he directed RD, production as well as commercialization of products and technologies during the growth of this company
  Executive Since 2009  Ph.D    
61 7 3219 0085  http://www.anteodx.com
Maeji holds a Ph.D. in Polymer Engineering from the Tokyo Institute of Technology.

Management Efficiency

The company has return on total asset (ROA) of (2.66) % which means that it has lost $2.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (68.77) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 667.7 K in total debt with debt to equity ratio (D/E) of 11.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Anteo Diagnostics Limited has Current Ratio of 1.15 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Alexandra HolcombWestpac Banking Corporation
2014
David LindbergWestpac Banking Corporation
2015
Tim PaineRio Tinto Limited
2012
Arnaud SoiratRio Tinto Limited
2016
Alan DaviesRio Tinto Limited
2012
Alfredo PrietoRio Tinto Limited
2014
Melanie LaingCommonwealth Bank of Australia
2012
Hugo BagueRio Tinto Limited
2013
Stephen McIntoshRio Tinto Limited
2016
Simone NivenRio Tinto Limited
2017
Debra ValentineRio Tinto Limited
2009
Anna LenahanCommonwealth Bank of Australia
2016
David OvingtonRio Tinto Limited
2017
David WhiteingCommonwealth Bank of Australia
2014
Andrew CuthbertsonCSL Limited
2000
Alden ToevsCommonwealth Bank of Australia
2008
Kevin CorballyAustralia and New Zealand Banki
2016
Maile CarnegieAustralia and New Zealand Banki
2016
Rebecca LimWestpac Banking Corporation
2017
Harry KenyonSlaneyRio Tinto Limited
2012
Michael LiarakosAustralia and New Zealand Banki
2016

Entity Summary

Anteo Diagnostics Limited, a medical technology company, develops and commercializes specialized surfaces for use in life sciences industries in Australia. Anteo Diagnostics Limited (ADO) is traded on Australian Securities Exchange in Australia. It is located in Eight Mile Plains, QLD and employs 99 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Anteo Diagnostics Limited to your portfolio

Top Management

Anteo Diagnostics Limited Leadership Team
Nobuyoshi Maeji, Executive, Ph.D
Alan Studley, Director, CPA
Mark Bouris, Chairman
Peter HardingSmith, CFO
Matthew Sanderson, Director
John Hurrell, Director, Ph.D
Stefan Enderling, CEO, Ph.D
Geoffrey Cumming, CEO
Tamara Mills, COO
Julien McInally, Executive, CPA
Shane Hartwig, Executive
Nevin Abernethy, Executive
Richard Martin, Director
Jef Vangenechten, CEO, Ph.D
Rolf Sickman, Director
Sandra Andersen, Director, CPA

Stock Performance

Anteo Diagnostics Performance Indicators